Literature DB >> 19332121

Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells.

Victor S Van Laar1, Amanda J Mishizen, Michael Cascio, Teresa G Hastings.   

Abstract

Dopamine oxidation has been previously demonstrated to cause dysfunction in mitochondrial respiration and membrane permeability, possibly related to covalent modification of critical proteins by the reactive dopamine quinone. However, specific mitochondrial protein targets have not been identified. In this study, we utilized proteomic techniques to identify proteins directly conjugated with (14)C-dopamine from isolated rat brain mitochondria exposed to radiolabeled dopamine quinone (150 microM) and differentiated SH-SY5Y cells treated with (14)C-dopamine (150 microM). We observed a subset of rat brain mitochondrial proteins that were covalently modified by (14)C-dopamine, including chaperonin, ubiquinol-cytochrome c reductase core protein 1, glucose regulated protein 75/mitochondrial HSP70/mortalin, mitofilin, and mitochondrial creatine kinase. We also found the Parkinson's disease associated proteins ubiquitin carboxy-terminal hydrolase L1 and DJ-1 to be covalently modified by dopamine in both brain mitochondrial preparations and SH-SY5Y cells. The susceptibility of the identified proteins to covalent modification by dopamine may carry implications for their role in the vulnerability of dopaminergic neurons in Parkinson's disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332121      PMCID: PMC2759724          DOI: 10.1016/j.nbd.2009.03.004

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  102 in total

1.  Toward a clinical molecular scanner for proteome research: parallel protein chemical processing before and during western blot.

Authors:  W V Bienvenut; J C Sanchez; A Karmime; V Rouge; K Rose; P A Binz; D F Hochstrasser
Journal:  Anal Chem       Date:  1999-11-01       Impact factor: 6.986

Review 2.  Mitochondria on the move.

Authors:  Istvan R Boldogh; Liza A Pon
Journal:  Trends Cell Biol       Date:  2007-09-04       Impact factor: 20.808

3.  The parkinsonian toxin MPTP: action and mechanism.

Authors:  Serge Przedborski; Vernice Jackson-Lewis; Ruth Djaldetti; Gabriel Liberatore; Miquel Vila; Slobodanka Vukosavic; Gabrielle Almer
Journal:  Restor Neurol Neurosci       Date:  2000       Impact factor: 2.406

4.  Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain.

Authors:  F H Khan; M Saha; S Chakrabarti
Journal:  Brain Res       Date:  2001-03-23       Impact factor: 3.252

5.  Oxidative modification of nucleoside diphosphate kinase and its identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  E J Song; Y S Kim; J Y Chung; E Kim; S K Chae; K J Lee
Journal:  Biochemistry       Date:  2000-08-22       Impact factor: 3.162

6.  Mitochondrial oxidative phosphorylation defects in Parkinson's disease.

Authors:  J M Shoffner; R L Watts; J L Juncos; A Torroni; D C Wallace
Journal:  Ann Neurol       Date:  1991-09       Impact factor: 10.422

7.  Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.

Authors:  Joungil Choi; Allan I Levey; Susan T Weintraub; Howard D Rees; Marla Gearing; Lih-Shen Chin; Lian Li
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

8.  Inhibition of brain mitochondrial respiration by dopamine: involvement of H(2)O(2) and hydroxyl radicals but not glutathione-protein-mixed disulfides.

Authors:  Martin Gluck; Julie Ehrhart; Elizabeth Jayatilleke; Gail D Zeevalk
Journal:  J Neurochem       Date:  2002-07       Impact factor: 5.372

9.  Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

Authors:  M J LaVoie; T G Hastings
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

10.  Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

Authors:  Tanea Reed; Marzia Perluigi; Rukhsana Sultana; William M Pierce; Jon B Klein; Delano M Turner; Raffaella Coccia; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996

View more
  59 in total

Review 1.  Neurotoxins as Preclinical Models for Parkinson's Disease.

Authors:  Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-01-08       Impact factor: 3.911

2.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

3.  Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line.

Authors:  Irmgard Paris; Carolina Perez-Pastene; Sergio Cardenas; Patricio Iturriaga-Vasquez; Patricio Iturra; Patricia Muñoz; Eduardo Couve; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2010-01-20       Impact factor: 3.911

4.  Glutathione transferase-M2-2 secreted from glioblastoma cell protects SH-SY5Y cells from aminochrome neurotoxicity.

Authors:  Carlos Cuevas; Sandro Huenchuguala; Patricia Muñoz; Monica Villa; Irmgard Paris; Bengt Mannervik; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2014-11-18       Impact factor: 3.911

5.  Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-01-29       Impact factor: 3.911

Review 6.  Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.

Authors:  Aracely Garcia-Garcia; Laura Zavala-Flores; Humberto Rodriguez-Rocha; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

7.  One-electron reduction of 6-hydroxydopamine quinone is essential in 6-hydroxydopamine neurotoxicity.

Authors:  Monica Villa; Patricia Muñoz; Ulises Ahumada-Castro; Irmgard Paris; Ana Jiménez; Isabel Martínez; Francisca Sevilla; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

8.  Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction.

Authors:  Sandro Huenchuguala; Patricia Muñoz; Patricio Zavala; Mónica Villa; Carlos Cuevas; Ulises Ahumada; Rebecca Graumann; Beston F Nore; Eduardo Couve; Bengt Mannervik; Irmgard Paris; Juan Segura-Aguilar
Journal:  Autophagy       Date:  2014-01-14       Impact factor: 16.016

9.  The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.

Authors:  Teresa G Hastings
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

Review 10.  Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism.

Authors:  David N Hauser; Teresa G Hastings
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.